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Abstract
Objective: We aimed to investigate the association of the serum urate level
with cortical thickness and white matter integrity in multiple system atrophy
(MSA). Methods: We recruited 75 MSA patients and 42 controls who under-
went brain MRI and measured serum urate level at baseline. Using cortical
thickness and tract-based spatial statistics analyses, we investigated the correla-
tion between serum urate levels and cortical thickness or diffusion tensor imag-
ing (DTI) measures in controls and MSA patients. Interaction effects were
analyzed to find different patterns of correlation according to sex and clinical
subtype. We evaluated the relationship between serum urate levels, DTI mea-
sures, and total UMSARS score, using path analysis. Results: Serum urate levels
showed a positive correlation with FA values in the corpus callosum and a neg-
ative correlation with MD values in widespread regions including cerebellar,
brainstem, and cerebral white matter in patients with MSA. Both sexes showed
a negative correlation between serum urate levels and MD values without sig-
nificant interaction effect. In subgroup analysis according to subtype, patients
with cerebellar subtype showed a negative correlation. Serum urate levels did
not correlated with cortical thickness. Path analysis showed that MD values in
middle and inferior cerebellar peduncle mediated the association between serum
urate level and total UMSAR score. Interpretation: The present study demon-
strated that serum urate levels played a pivotal role in white matter disintegrity
and clinical disability in MSA. It would provide an evidence of the role of urate
as a potential neuroprotective factor against white matter neurodegeneration in
MSA.
Introduction
MSA is an adult-onset and sporadic neurodegenerative
disease that manifests as progressive autonomic failure,
parkinsonism, cerebellar syndrome, and pyramidal fea-
tures in various combinations.1 MSA is a relentlessly pro-
gressive disease with median disease duration of 7.5 years
from the onset of symptoms to death.2 Despite extensive
research and clinical trials, disease-modifying candidates
except stem cell therapy are not available.3 Pathologically,
MSA is regarded as a unique oligodendroglial a-synucle-
inopathy, and degeneration of myelin due to
oligodendroglial dysfunction is a leading event in the
pathogenesis of MSA, followed by neuronal death.4
Therefore, white matter alterations in supratentorial and
infratentorial areas were extensively detected in patients
with MSA, suggesting prominent dysfunction of myelin
connecting multiple brain systems throughout the cere-
bral regions.5–7
Urate, a natural antioxidant, has been reported to have
an association with the risk and progression of neurode-
generative diseases.8 A meta-analysis reported that low
serum urate levels were associated with an increased risk
of MSA.9,10 Patients with MSA having high serum urate
ª 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any
medium, provided the original work is properly cited.
1029
levels had slower disease progression than those with
lower levels.11 Although the role of serum urate in the
pathogenesis of MSA and its causality are currently
unknown, these studies suggest that urate may have a
close link to neurodegeneration in MSA, probably via
antioxidant effect.
In the present study, we hypothesized that serum urate
levels may be closely associated with the alterations in
gray matter thickness or white matter integrity in MSA.
In the present study, using the analyses of cortical thick-
ness and track-based spatial statistics (TBSS), we explored
the relationship between serum urate levels and cortical
thickness or quantitative white matter metrics such as




We consecutively recruited 75 patients with MSA and 42
normal controls from the Movement Disorders outpatient
clinic in the Yonsei University Health System from August
2011 to April 2018. Patients with MSA were diagnosed with
probable MSA, parkinsonian subtype (MSA-P), or cerebel-
lar subtype (MSA-C), based on the diagnostic criteria for
MSA.12 All patients had undergone the Unified MSA Rat-
ing Scale (UMSARS) part I to IV, Korean version of the
Mini-Mental State Examination (K-MMSE), brain mag-
netic resonance imaging (MRI), and either N-(3-[18F]fluo-
ropropyl)-2b-carbomethoxy-3b-(4-iodophenyl) nortro-
pane (FP-CIT) positron emission tomography (PET) or
18F-fluorodeoxyglucose (FDG) PET scan within 6 months.
UMSARS was performed to assess the disease severity at
the time of MRI acquisition. Total UMSARS score was
defined as the sum of UMSARS-I (historical), II (motor
examination), and IV (global disability scale) subscores. All
enrolled patients had a minimum K-MMSE score of 24.
The diagnosis of MSA was supported by structural and/or
functional imaging evaluations in all patients,12 including
atrophy on MRI of the putamen, middle cerebellar pedun-
cle, pons, or cerebellum; hypometabolism on FDG PET
scan in the putamen, brainstem, or cerebellum; and presy-
naptic nigrostriatal dopaminergic denervation on FP-CIT
PET scan. None of the patients had mutations in the SCA
1, 2, 3, 6, 7, 8, and 17 genes. We excluded the following
patients with: (1) focal brain lesions, severe white matter
hyperintensities, multiple lacunae in the basal ganglia, or
hydrocephalus on brain MRI; (2) total K-MMSE score less
than 24; (3) other major neurologic or psychiatric illnesses;
(4) diseases affecting purine turnover including chronic
renal disease, myeloproliferative disease, or chronic hemo-
lytic anemia; (5) a history of heavy alcohol consumption or
vegetarianism; and (6) antigout or diuretics medication. All
normal controls enrolled in this study had no active neuro-
logical disorders and normal cognitive function according
to the K-MMSE (scores ≥ 24). Additionally, body mass
index (kg/m2) and history of hypertension, diabetes melli-
tus, hyperlipidemia, cardiac disease, ischemic stroke, and
smoking were obtained in patients and controls.
The present study was approved by the Institutional
Review Board of Yonsei University College of Medicine.
Written informed consent was obtained from all patients
and healthy controls who participated in this study.
Measurement of serum urate level
Urate level was measured in serum samples collected on
the morning of MRI acquisition day after fasting over-
night because the serum urate level could be affected by
diurnal variation and food ingestion.13 The level of serum
urate was determined by an enzymatic colorimetric
method using an automatic analyzer (Hitachi 7600; Hita-
chi, Tokyo, Japan).
Neuroimaging acquisition
We acquired high-resolution T1-weighted MRI data and
diffusion tensor imaging (DTI) from all participants using
a Philips 3T scanner (Philips Intera, Philips Medical Sys-
tem). A detailed description is provided in Method S1.
Processing of DTI data
The Functional MRI of Brain (FMRIB) Software Library
(FSL) (http://www.fmrib.ox.ac.uk/fsl) was used to prepro-
cess the DTI data.Detailed description is provided in
Method S2.
Processing of high-resolution T1-weighted
MR data
We used the same methodology that we employed in a
previous study,14 and a detailed description is provided in
Method S3.
Analyses of cortical thickness and TBSS
While comparing the localized differences in the DTI mea-
sures (FA and MD) and cortical thickness between normal
controls and MSA, we performed voxel-wise group com-
parison of individual skeleton images using a nonparamet-
ric permutation test, after controlling for age and sex in the
comparison between the MSA patients and the normal con-
trols and for age, disease duration, and total UMSARS score
in the comparison between male and female MSA patients.
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To investigate the correlation between serum urate
levels and DTI measures or cortical thickness, we per-
formed a voxel-wise correlation analysis using a nonpara-
metric permutation test. In all MSA patients and patients
with MSA-C and MSA-P, we used age, sex, disease dura-
tion, and total UMSARS score as covariates. In male and
female MSA patients, we used age, disease duration, and
total UMSARS score as covariates. We also examined the
interaction between the serum urate and sex and between
the serum urate and clinical subtype to investigate the
differential effect of the serum urate on the DTI measures
according to sexes and clinical subtype.
The null distribution of all permutation tests in this
study was built over 5000 permutations. We used the
threshold-free cluster enhancement with the two-dimen-
sional parameter settings15 to avoid an arbitrary threshold
of the initial cluster formation. Corrections for multiple
comparisons were performed using family-wise error rate
in diffusion tensor imaging analysis and random field the-
ory in cortical thickness analysis respectively. The thresh-
old was set at corrected P < 0.05.
Statistical analyses
The baseline demographic and clinical characteristics of
patients with MSA were analyzed, using Student’s t-tests
for continuous variables, while Pearson’s v2 tests were
used to analyze categorical variables. As there were signifi-
cant relationship between the serum urate, DTI measures,
and total UMSARS score, we performed path analyses to
evaluate whether DTI measures mediated the association
between the serum urate and total UMSARS score after
controlling for age, sex, and disease duration. Among the
regions where there were significant correlation between
the serum urate and DTI measures in all MSA patients,
those showing significant association with total UMSARS
score were selected as predictors for path analyses. We
used a bootstrapping method with 500 resamples to
derive the 95% confidence intervals and standard errors.
The data were analyzed using SPSS software 23 (IBM
Corporation, Armonk, NY) and AMOS software 23 (IBM
Corporation, Armonk, NY). P values < 0.05 were consid-
ered significant.
Results
Demographic and clinical characteristics
The baseline demographic and clinical characteristics of the
study subjects are summarized in Table 1. Patients with
MSA had lower serum urate levels and K-MMSE scores
than the control subjects. Male patients with MSA had
lower K-MMSE scores than the male controls, while female
patients with MSA had lower K-MMSE scores and serum
urate levels than the female controls. Male patients with
MSA had significantly higher levels of urate than the
female patients with MSA (5.4  1.3 vs. 3.6  0.9,
P < 0.001). Other characteristics were not significantly dif-
ferent between the MSA patients and the control groups
and between the male and the female patient groups.
Group comparison of white matter integrity
and cortical thickness
When compared with the normal controls, patients with
MSA had lower FA values and higher MD values in wide-
spread brain areas including cerebellar, brainstem, and
cerebral white matter (Fig. S1A). They also had lower
cortical thickness in the left primary motor and premotor
cortices and bilateral lateral temporal, insular, lateral and
medial occipital, posterior cingulate, and retrosplenial
cortices. In MSA group, neither FA and MD values nor
cortical thickness were significantly different between the
male and the female MSA patients (Fig. S1B).
Correlation between serum urate levels and
white matter integrity or cortical thickness
in normal controls and MSA
In the control group, serum urate levels showed no corre-
lation with FA and MD values and cortical thickness
(Fig. 1A). In the MSA group, serum urate levels showed
positive correlation with FA values in the corpus callosum,
especially in the genu and the body portions. The urate
levels in the MSA group showed negative correlation with
MD values in the widespread brain areas including cerebel-
lar, brainstem, and cerebral white matter (Fig. 1B).
Correlation between serum urate levels and
white matter integrity or cortical thickness
in MSA according to sex
Since serum urate levels were significantly different
between the sexes, we performed subgroup analysis
according to sexes. In male patients with MSA, serum
urate levels showed negative correlation with MD values
in the corpus callosum, especially the body portion, and
the left temporo-parietal white matter (Fig. 2A), but
showed no correlation with FA values or cortical thick-
ness. In female patients with MSA, serum urate levels
showed negative correlation with MD values in the left
fronto-parietal white matter (Fig. 2B), but showed no sig-
nificant association with FA values or cortical thickness.
Interaction analysis showed that there was no urate by
sex interaction effect on FA and MD values or cortical
thickness.
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Correlation between serum urate levels and
white matter integrity or cortical thickness
in MSA according to clinical subtype
In patients with MSA-C, serum urate levels showed nega-
tive correlation with MD values in widespread brain
regions including cerebellar, brainstem, and cerebral white
matter (Fig. 3A), whereas serum urate levels had no sig-
nificant correlation with FA values or cortical thickness.
In patients with MSA-P, serum urate levels showed no
correlation with FA and MD values or cortical thickness
(Fig. 3B). Interaction analysis showed that there was no
urate by MSA subtype interaction effect on FA and MD
values or cortical thickness.
Relationship among serum urate levels, DTI
measures, and total UMSARS score
Since there were correlations between serum urate levels,
MD values in certain regions, and total UMSARS score, we
performed path analyses to investigate the relationship of
these variables. We set a hypothetical model, using the
serum urate level as a predictor, DTI measures as a media-
tor, and total UMSARS score as an outcome variable. Path
analyses showed that among white matter regions, mean
diffusivity in middle and inferior cerebellar peduncles medi-
ated the association between serum urate level and total
UMSARS score with goodness of fit (Fig. 4; Table S1).
Discussion
The present study assessed the association of serum urate
levels with cortical thickness and white matter integrity in
patients with MSA. We found that serum urate levels were
not correlated with cortical thickness but with white matter
integrity irrespective of sex. The association was exclusively
observed in patients with MSA-C. White matter disintegrity
in middle and inferior cerebellar peduncles mediated the
association between serum urate level and total UMSARS
score. These findings suggest that urate is closely linked to
white matter integrity and disease severity in MSA.
Accumulating evidence has suggested the role of oxida-
tive stress in the pathogenesis of MSA. Experimental stud-
ies have demonstrated that mitochondrial dysfunction
Table 1. Demographic characteristics of patients with multiple system atrophy and healthy control.















Number of subjects 75 42 42 22 33 20
Age at onset, y 58.5  8.7 61.5  6.0 0.094 57.7  9.2 60.5  6.7 0.122 59.5  7.9 60.4  5.0 0.613 0.381
Disease duration, y 2.1  1.3 NA – 1.9  1.1 NA – 2.3  1.5 NA – 0.140
Serum urate, mg/dL 4.6  1.5 5.2  1.3 0.044 5.4  1.3 5.8  1.4 0.212 3.6  0.9 4.4  0.6 0.001 <0.001
Body mass index,
kg/m2
23.9  3.2 24.7  3.3 0.241 24.6  2.8 25.2  3.4 0.436 23.2  3.5 24.1  3.2 0.321 0.058




MSA-P 35 (46.7) NA – 17 (40.5) NA – 18 (54.5) NA –
MSA-C 40 (53.3) NA – 25 (59.5) NA – 15 (45.5) NA –
Total UMSARS score 35.3  17.0 NA – 35.4  13.5 NA – 41.2  17.8 NA – 0.069
Part I 16.8  8.1 NA – 16.1  6.6 NA – 18.5  8.5 NA – 0.247
Part II 17.4  8.7 NA – 15.9  6.1 NA – 20.4  8.5 NA – 0.113
Part IV 1.9  1.0 NA – 1.8  0.8 NA – 2.0  1.0 NA – 0.346
Vascular risk factors, n (%)
Hypertension 21 (28.0) 15 (35.7) 0.386 12 (28.6) 9 (40.9) 0.104 9 (27.3) 6 (30.0) 0.775 0.962
Diabetes mellitus 14 (18.7) 5 (11.9) 0.341 9 (21.4) 3 (13.6) 0.126 5 (15.2) 2 (10.0) 0.635 0.255
Dyslipidemia 10 (13.3) 8 (19.0) 0.411 6 (14.3) 3 (13.6) 0.685 4 (12.1) 5 (25.0) 0.070 0.440
Cardiac disease 3 (4.0) 5 (11.9) 0.104 2 (4.8) 4 (18.2) 0.199 1 (3.0) 1 (5.0) 0.278 0.207
Ischemic stroke 3 (4.0) 0 (0.0) 0.189 2 (4.8) 0 (0.0) 0.217 1 (3.0) 0 (0.0) 0.217 0.207
Current smoking 10 (13.3) 11 (26.2) 0.082 8 (19.0) 9 (40.9) 0.060 2 (6.1) 2 (10.0) 0.599 0.170
Values are expressed as mean  standard deviation or number (percentage).
K-MMSE, the Korean version of Mini-Mental State Examination; MSA, multiple system atrophy; NC, normal controls; NA, not applicable; RBD,
rapid eye movement sleep behavior disorder; UMSARS, Unified Multiple System Atrophy Rating System.
1P-value < 0.05 between MSA versus control.
2P-value < 0.05 between male MSA versus male control.
3P-value < 0.05 between female MSA versus female control.
4P-value < 0.05 between male MSA versus female MSA.
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and oxidative stress are possible risk factors for triggering
or exacerbating the MSA pathology.16,17 In case–control
epidemiological studies, it has been observed that occupa-
tional exposure to pesticides, insecticides, or solvents
interrupting the mitochondrial electron transport and
leading to oxidative stress may increase the risk of
MSA.18-20 Low levels of reduced glutathione and high
levels of iron content in the oligodendrocytes and
Figure 1. White matter integrity and cortical thickness associated with serum urate levels (A) in normal controls and (B) in patients with MSA.
Results are based on general linear models using serum urate levels as a predictor and controlling for age, sex, disease duration, and total Unified
MSA Rating Scale score. Corrections for multiple comparisons were performed using family-wise error rate in diffusion tensor imaging analysis
and random field theory in cortical thickness analysis respectively. Red to yellow color in corrected P-map indicates regions showing significant
positive correlations with serum urate levels. Blue color in corrected P-map indicates regions showing significant negative correlations with serum
urate levels. The threshold was set at corrected P < 0.05. The brain images were displayed in neurological convention.
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oligodendrocyte progenitors contribute to this vulnerabil-
ity to oxidative stress.21,22 Since MSA is an oligoden-
droglial a-synucleinopathy, it can be inferred that
oligodendroglial cytoplasmic inclusions may increase the
oxidative stress.23 Conversely, oxidative stress can aggra-
vate the accumulation of a-synuclein in
Figure 2. White matter integrity and cortical thickness associated with serum urate levels according to sex. General linear models were
performed to investigate the correlation between serum urate levels and the diffusion tensor imaging measures or cortical thickness in (A) male
and (B) female patients with MSA, after controlling for age, disease duration, and total Unified MSA Rating Scale score. Corrections for multiple
comparisons were performed using family-wise error rate in diffusion tensor imaging analysis and random field theory in cortical thickness analysis
respectively. Red to yellow color in corrected P-map indicates regions showing significant positive correlations with serum urate levels. Blue color
in corrected P-map indicates regions showing significant negative correlations with serum urate levels. The brain images were displayed in
neurological convention.
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oligodendrocytes.24 Both of these events result in
impaired myelination and white matter degeneration in
MSA. In the present study, we provide the evidence for
the first time that higher levels of serum urate were clo-
sely associated with less severe white matter disintegrity
in widespread brain areas. This result suggests a protective
Figure 3. White matter integrity and cortical thickness associated with serum urate levels according to clinical subtype. General linear models
were performed to investigate the correlation between serum urate levels and the diffusion tensor imaging measures or cortical thickness in MSA
patients (A) with cerebellar subtype and (B) with parkinsonian subtype, after controlling for age, sex, disease duration, and total Unified MSA
Rating Scale score. Corrections for multiple comparisons were performed using family-wise error rate in diffusion tensor imaging analysis and
random field theory in cortical thickness analysis respectively. Red to yellow color in corrected P-map indicates white matter regions showing
significant positive correlations with serum urate levels. Blue color in corrected P-map indicates white matter regions showing significant negative
correlations with serum urate levels. The brain images were displayed in neurological convention.
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role of urate against white matter damage through its
mediating antioxidant property.
In line with our study, previous imaging studies have
consistently demonstrated white matter disintegrity in
extensive supratentorial and infratentorial structures in
patients with MSA.5,6 Importantly, we found in this study
that serum urate levels had a significant correlation with
MD values in widespread brain regions, whereas the rela-
tionship between serum urate levels and FA values was
localized in the corpus callosum. Since MD is an average
of eigenvalues of three axes, it reflects the magnitude of
water diffusion that is sensitive to cellular structure and
edema.25 Meanwhile, FA quantifies the preferential direc-
tion of water diffusion along the white matter tracts that
is sensitive to microstructural features including axonal
density and myelination.26 Since urate is related to oxida-
tive stress, which can further induce neuroinflamma-
tion,27 it can be inferred that urate may be more closely
associated with impaired tissue barrier and increased
water diffusivity around degenerated white matter tissue
due to neuroinflammation than to decreased directional-
ity of white matter tract. Among the areas with altered
white matter in MSA, the corpus callosum showed signifi-
cant correlation between serum urate levels and both DTI
measures. It is known that the corpus callosum is a major
white matter region of accumulation of glial cytoplasmic
inclusions,28 via which spread of a-synuclein from both
hemispheres might occur.29 In postmortem tissue of MSA
patients, the corpus callosum showed increased neuroin-
flammation with high a-synuclein load.30 Thus, the cor-
pus callosum may be a principal site of myelin
dysfunction and axonal injury that is vulnerable to oxida-
tive stress in MSA.
Several studies have reported sex differences in the neu-
roprotective effect of urate in various neurodegenerative
disorders. In Parkinson’s disease, high urate levels have
consistently been associated with lower risk among men,
while the association was weaker and inconsistent among
women.31,32 Urate levels also predicted survival in men
with amyotrophic lateral sclerosis.33 Similarly, modulatory
effect of urate on the risk and disease progression in MSA
has been observed in male patients.9,10 However, in this
study, the association between serum urate levels and white
matter disintegrity was observed in both male and female
Figure 4. Schematic diagram of the path analyses. Serum urate level and mean diffusivity in middle cerebellar peduncle or inferior cerebellar
peduncle were entered as predictors for total UMSARS score. Age, sex, and disease duration were entered as covariates.
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patients without significant urate by sex interaction, in
spite of difference in the mean serum urate levels between
sexes. These results imply that urate may be protective
against white matter degeneration in MSA patients irre-
spective of sex. Because serum urate concentrations were
typically higher in men than in women, the antioxidative
effects of urate seems more likely to be seen in men.. How-
ever, some studies have reported an inverse association
between urate and Parkinson’s disease risk even in female
patients,31,34 which is consistent with our results. Since
estrogen has an inverse correlation with serum urate
levels35 and a protective effect on neurodegeneration and
neuroinflammation,36,37 it is inappropriate to apply the
antioxidant effect of absolute serum urate levels equally to
both sexes. Future studies focusing on sex-specific antioxi-
dant effect of urate in MSA are warranted.
Subgroup analysis according to the clinical subtypes of
MSA revealed that the correlation between urate and
white matter degeneration was primarily observed in
MSA patients with predominant cerebellar type. Despite
the common pathological findings of oligodendroglial
cytoplasmic inclusions, MSA-P and MSA-C are different
in terms of clinical, neuropathological, and imaging char-
acteristics.1 Although the mechanism that determines the
clinically different subtypes in MSA remains largely
unknown, we can infer from this study that oxidative
stress may play a pivotal role in the pathogenesis of phe-
notypic heterogeneity in MSA. This result also has an
implication for trial design that targets antioxidation as a
disease-modifying therapy in MSA.
Path analysis revealed that white matter disintegrity in
cerebellar peduncle mediated the association of serum
urate level with disease severity in MSA. Consistent with
our results, a previous study has reported that patients
with MSA showed a negative correlation between serum
urate level and disease severity.38 Imaging studies using
DTI have demonstrated that ataxia scale was associated
with FA values in cerebellar white matter, middle cerebellar
peduncle, and posterior limb of internal capsule and with
MD values in cerebellar white matter in MSA-C.6 These
studies suggest that serum urate and white matter disin-
tegrity are closely interacted with disease severity in MSA.
Pathological studies have reported that in MSA, there are
neuronal loss, deposition of glial cytoplasmic inclusion,
and extensive myelin loss in medullo-ponto-cerebellar
regions, which are interconnected by middle and inferior
cerebellar peduncles.39 Considering the important role of
oxidative stress in degeneration of oligodendrocyte,40 urate
may engage in modulation of MSA-related white matter
degeneration, which in turn, could affect clinical manifesta-
tion of MSA. Thus, it is plausible that cerebellar peduncle
may be an important anatomical substrate linking oxida-
tive stress and disease severity in MSA.
The present study has several limitations. First, the
cross-sectional design limited to identify a causal relation-
ship between serum urate levels and white matter disin-
tegrity. Longitudinal study studies are required to
elucidate the protective role of urate in white matter
degeneration. Second, there are many risk factors associ-
ated with hyperuricemia or white matter integrity that
may interfere with the assessment of independent rela-
tionship between urate and white matter integrity, such
as cognitive function, smoking, diet, body mass index,
and renal function. To generalize the results, a larger sam-
ple size is required, adjusting a sufficient number of
important variables and strictly matching the controls.
Third, we recruited MSA patients with varying disease
duration and severity. Association of urate and white
matter integrity according to disease duration or severity
might present a different pattern of the role of urate as
an antioxidant as the neurodegeneration progresses.
Fourth, pathologic evaluation was not performed in all
patients. Such an evaluation may help in studying the
definite relationship between serum urate levels and the
degree of demyelination or axonal injury.
The present study demonstrated that serum urate
levels played a pivotal role in microstructural white mat-
ter disintegrity and clinical disability in patients with
MSA. The results of the present study provide potential
evidence that therapy targeting serum urate levels may
be a possible candidate for disease-modifying therapy in
MSA.
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